YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
106 hedge funds and large institutions have $819M invested in Y-mAbs Therapeutics in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
106
Holders Change
-3
Holders Change %
-2.75%
% of All Funds
2.14%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
10
Increased
42
Reduced
38
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.6M |
| 2 |
Goldman Sachs
New York
|
+$5.61M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$4.39M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$3.81M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.62M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$15.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.53M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$6.79M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.67M |
| 5 |
Two Sigma Investments
New York
|
-$2.12M |
